Opioid Use Disorder Market Outlook, Competitive Landscape and Forecasts to 2027
Wilmington, Delaware, United States, Transparency Market Research Inc.: Opioids are used for pain relief. They have a depressant effect on the central nervous system as well as the potential to cause euphoria. Opioid use disorder (OUD) can occur, due to misuse or overdose of prescribed opioid medications.
Two types of patients suffer from OUD: patients who are addicted to non-medical opioids and patients addicted to medical opioids
Read Report Overview - https://www.transparencymarketresearch.com/opioid-use-disorder-market.html
Most commonly abused opioids are codeine, oxycodone, hydrocodone, morphine, and fentanyl. Physical dependence is the most harmful long-term effect and withdrawal symptoms occur if opioid use is abruptly reduced.
Current treatments are based on medication-assisted treatment (MAT) with an opioid agonist or an opioid antagonist. They involve use of medication along with counseling and behavioral therapies.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=75167
Key Drivers and Restraints of Global Opioid Use Disorder Market
Increasing incidence of opioid use disorder is a major factor likely to drive the global market during the forecast period. According to American Psychiatric Association, in 2017, around 72,000 people in the U.S. died of overdose of drugs, which included illicit drugs and prescription opioids. According to the Center for Disease Control and Prevention (CDC), over 15,000 people in the U.S. died of heroin overdose in 2017.
Increasing research and development activities and wide product pipeline are other factors estimated to fuel the global opioid use disorder market during the forecast period. For instance, Orexo AB, a major manufacturer of opioid use disorder treatment products, has introduced an innovative product in its pipeline i.e. OXD01.
Lack of awareness and limited product availability are restraining the global opioid use disorder market
Buprenorphine Drugs to Witness High Demand
Based on drug type, the global opioid use disorder market can be segmented into buprenorphine, methadone, and naltrexone
The buprenorphine segment accounted for the maximum share of the global opioid use disorder market in 2018. The segment is expected to dominate the global market from 2019 to 2027, due to increasing demand for buprenorphine-containing products such as bunavail, sublocade, suboxone, and zubsolv. Suboxone is the most widely prescribed drug for treatment of opioid use disorder, due to its high efficacy in managing opioid addiction, low adverse effect, and its favorable formulary coverage.
Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=75167
Hospital Pharmacies to be Most Promising Segment
In terms of distribution channel, the global opioid use disorder market can be divided into hospital pharmacies, retail pharmacies, and online sales. The hospital pharmacies segment generated the maximum revenue in 2018 and it is anticipated to witness significant growth during the forecast period. A majority of opioid use disorder treatment products are prescription products and they are mostly available in hospital pharmacies.
North America to Dominate Global Opioid Use Disorder Market
In terms of region, the global opioid use disorder market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America dominated the global opioid use disorder market in 2018 and it is expected to maintain its leading position throughout the forecast period. Dominance of the region can be attributed to expansion of product offerings by market players, favorable government initiatives, and presence of key market players in the region. For instance, in January 2018, the U.S. Government launched an awareness campaign to combat opioid addiction.
The market in Asia Pacific is projected to register the maximum growth rate during the forecast period, owing to increase in the adoption of new products and rise in the incidence of opioid use disorder
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=75167
Key Manufacturers Operating in Global Market
The global opioid use disorder market was highly fragmented in 2018. Major manufacturers operating in the global market are:
- Indivior PLC
- Alkermes
- Teva Pharmaceutical Industries Ltd.
- MediciNova, Inc.
- Hikma Pharmaceuticals
- Orexo AB
- Camurus AB
- Omeros Corporation
More Trending Reports by Transparency Market Research –
Nonalcoholic Steatohepatitis Therapeutics Market: The global tablet coatings market is anticipated to reach more than US$ 1,543 Mn by 2031.The global market is projected to expand at a CAGR of 5.3% from 2022 to 2031
Bruise Treatment Market: The global bruise treatment market is estimated to register growth at a CAGR of 3.5% during the forecast period from 2022 to 2031
Psoriasis Treatment Market: The global life science reagents market is expected to reach more than US$ 100 Bn by the end of 2031.The global market is projected to grow at a CAGR of 5.7% from 2022 to 2031
Life Science Reagents Market: The global life science reagents market is expected to reach more than US$ 100 Bn by the end of 2031.The global market is projected to grow at a CAGR of 5.7% from 2022 to 2031
Liquid Filled Hard Capsules Market: The global liquid filled hard capsules market is anticipated to reach more than US$ 4 Bn by the end of 2031.The global market is projected to grow at a CAGR of 7.8% from 2022 to 2031
Antihypertensive Drugs Market: The global antihypertensive drugs market is anticipated to reach more than US$ 40 Bn by the end of 2031.The global market is projected to grow at a CAGR of 3.0% from 2022 to 2031
U.S. Controlled Substance Market: The U.S. controlled substance market is expected to reach a value of US$ 74.3 Bn by the end of 2031.It is estimated to expand at a CAGR of 5.2% from 2022 to 2031
Tablet Coatings Market: The global tablet coatings market is anticipated to reach more than US$ 1,543 Mn by 2031.The global market is projected to expand at a CAGR of 5.3% from 2022 to 2031
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com